Investigation of influence of genetic polymorphisms of drug metabolizing enzymes and transporters, including SLCO1B3 and ABCC2, on Docetaxel Pharmacokinetics in advanced Non Small Cell Lung Cancer Patients
Not Applicable
Recruiting
- Conditions
- on-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000003723
- Lead Sponsor
- Research institute for diseases of the chest, Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of poorly controlled pleural effusion, pericardial effusion and ascites. 2)Active infection 3)Previous severe drug allergy 4)Hoped to be pregnant/nursing. 5)Symptomatic brain metastasis 6)Active concomitant malignancy 7)History of poorly controlled diabetes mellitus 8)History of severe complicating disease 9)simultaneous use of other anti-cancer drugs 10)Those judged to be not suitable by the attending physician 11)History of bone-marrow transplantation 12)Those who received a white blood cell transfusion within 30 days before registration
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method